Researchers examine novel medications or therapies in pre-approval clinical trials for kidney disorders using exacting study procedures meant to gauge their pharmacokinetics, pharmacodynamics, and clinical efficacy in patients at different stages of kidney failure. The goal of post-approval clinical research on renal illnesses is to assess approved medicines and interventions for real-world effectiveness, safety, and long-term safety.